IGC Pharma (IGC) Receivables (2011 - 2026)
IGC Pharma (IGC) posted Receivables of $694,000 for Q4 2026, down 2.8% from $714,000 a year earlier but up 2.2% from the prior quarter.
Powered by 
Analysis
IGC Pharma (IGC) Receivables (2011 - 2026) Analysis & Trends
Since Q4 2011, IGC Pharma has reported Receivables for 61 quarters.
- Annual Receivables has declined for three consecutive years, though with a five-year compound annual growth rate of 4.5% (FY2021 to FY2026).
- In prior years, IGC Pharma's Receivables was $714,000 in FY2025 (-1.5%), $725,000 in FY2024 (-31.5%), $1.06 million in FY2023 (+114.6%) and $493,000 in FY2022 (-11.5%).
- Quarterly Receivables has run from a low of $493,000 in Q4 2022 to a high of $1.18 million in Q1 2024 over five years.
- On a year-over-year basis, Receivables has declined in each of the last three quarters, with an average decline of 13.5% over the last eight quarters.
- The strongest year-over-year quarter for Receivables in the past five years was Q1 2024, with growth of 134.7%; the weakest was Q1 2025, with a decline of 39.3%.
- According to Business Quant data, Receivables for the three prior quarters was $679,000 (Q3 2026), $711,000 (Q2 2026) and $767,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 2.13 Bn |
| 10 | IGC Pharma | 26.67 Mn | 23.92 Mn | 55,000.00 | 694,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 694,000.00 |
| Dec 31, 2025 | 679,000.00 |
| Sep 30, 2025 | 711,000.00 |
| Jun 30, 2025 | 767,000.00 |
| Mar 31, 2025 | 714,000.00 |
| Dec 31, 2024 | 728,000.00 |
| Sep 30, 2024 | 729,000.00 |
| Jun 30, 2024 | 714,000.00 |
| Mar 31, 2024 | 725,000.00 |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 1.18 Mn |
| Mar 31, 2023 | 1.06 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 940,000.00 |
| Jun 30, 2022 | 501,000.00 |
| Mar 31, 2022 | 493,000.00 |
| Dec 31, 2021 | 546,000.00 |
| Sep 30, 2021 | 514,000.00 |
| Jun 30, 2021 | 537,000.00 |
API Access
IGC Pharma Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=IGC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "IGC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=IGC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();